GUSHENGTANG Aktie

>GUSHENGTANG Performance

1 Woche: -0,7%

1 Monat: +2,1%

3 Monate: -1,4%

6 Monate: -16,3%

1 Jahr: -28,7%

laufendes Jahr: -1,4%

>GUSHENGTANG Aktie

Name:

GUSHENGTANG HLD.DL-,0001

Land:

China

Sektor:

Gesundheit

ISIN/ Wkn:

KYG4212K1040 / A3DFAF

Symbol/ Ticker:

F2P (Frankfurt)

Kürzel:

FRA:F2P, ETR:F2P, F2P:GR

Index:

Webseite:

https://www.gstzy.cn/

Profil:

Gushengtang Holdings Ltd. is a key player in the healthcare sector, primarily recognized for its expansive chain of traditional Chinese medicine (TCM) services. The company focuses on providing integrated health and wellness solutions, combining the ..
>Volltext..

Marktkapitalisierung:

698.72 Mio. EUR

Unternehmenswert:

Umsatz:

EBITDA:

Nettogewinn:

Gewinn je Aktie:

Schulden:

Liquide Mittel:

Operativer Cashflow:

Bargeldquote:

Umsatzwachstum:

Gewinnwachstum:

Dividende je Aktie:

0.08 EUR

Dividendenrendite:

2.83%

Dividendenschätzung:

2.88%

Div. Historie:

11.09.25 - 0.038654€
24.06.25 - 0.0452804€

>weitere anzeigen...

Insiderhandel:

Suchwörter:

GUSHENGTANG

Letzte Datenerhebung:

06.04.26

>GUSHENGTANG Kennzahlen

Aktien/ Unternehmen:

Aktien: 231.52 Mio. St.

Frei handelbar: 60.34%

Leerverk. Aktien: -

Rückkaufquote: -

Mitarbeiter: 2915

Umsatz/Mitarb.: 0.13 Mio. EUR

Analysten:

Analystenrating: Strong buy

Kursziel: 53.04%

Bewertung:

KGV: -

KGV lG: 12.08

KUV: -

KBV: -

PEG-Ratio: -

EV/EBITDA: -

Rentabilität:

Bruttomarge: -

Gewinnmarge: -

Operative Marge: -

Managementeffizenz:

Gesamtkaprendite: -

Eigenkaprendite: -

>GUSHENGTANG Peer Group

Gesundheit

>GUSHENGTANG Chart & Kurs - Frankfurt
- Boerse Frankfurt
- >Profi Charts

>GUSHENGTANG News

31.03.26 - 19:00	Results: GUSHENGTANG Full-Year Net Profit RMB353 Million, Up 15%; Final Dividend HKD0.69 (AAStocks)
	GUSHENGTANG (02273.HK) announced its results for the fiscal year 2025, with revenue of RMB3.249 billion, representing a year-on-year increase of 7.5%. Gross profit was RMB1.012 billion, up 11.3%. The company recorded a net profit of RMB353 million, growing by 15%, with earnings per share of RMB1.49. A final dividend of HKD0.69 w......

13.01.26 - 05:45	Research: CMBI Ratings, TPs on Pharma (Table) (AAStocks)
	Shares \| Ratings \| Target prices (HK$)3SBIO(01530.HK) \| Buy \| 37.58 GUSHENGTANG(02273.HK) \| Buy \| 44.95 SINO BIOPHARM(01177.HK) \| Buy \| 9.4 WUXI XDC(02268.HK) \| Buy \| 74 ~AAStocks Financial NewsWeb Site: www.aastocks.com...

23.12.25 - 03:15	Research: CMBI Ratings, TPs on Pharmas (Table) (AAStocks)
	Shares \| Ratings \| Target prices (HK$)3SBIO(01530.HK) \| Buy \| 37.58 GUSHENGTANG(02273.HK) \| Buy \| 44.95 WUXI XDC(02268.HK) \| Buy \| 74 SINO BIOPHARM(01177.HK) \| Buy \| 9.4 ~AAStocks Financial NewsWeb Site: www.aastocks.com...

09.09.25 - 23:51	XFRA: DIVIDEND/INTEREST INFORMATION - 11.09.2025 - KYG4212K1040 (XETRA)
	Das Instrument F2P KYG4212K1040 GUSHENGTANG HLD.DL-,0001 EQUITY wird cum Dividende/Zinsen gehandelt am 10.09.2025 und ex Dividende/Zinsen am 11.09.2025 The instrument F2P KYG4212K1040 GUSHENGTANG HLD.DL-,0001 EQUITY has its pre-dividend/interest day on 10.09.2025 and its ex-dividend/interest day on 11.09.2025...

08.09.25 - 09:27	Gushengtang′s H1 2025 Net Profit Climbs 41.6% Driven by Digital Health Adoption and International Expansion (PR Newswire)
	GUANGZHOU, China, Sept. 8, 2025 /PRNewswire/ -- On August 29, Gushengtang (HKG:2273) announced its interim results for 2025, reporting strong operational and financial performance. The company posted revenue of RMB 1.49 billion, representing a 9.5% year-on-year increase. Net profit grew......

22.06.25 - 22:06	XFRA: DIVIDEND/INTEREST INFORMATION - 24.06.2025 - EQUBF_01 (XETRA)
	Das Instrument F2P KYG4212K1040 GUSHENGTANG HLD.DL-,0001 EQUITY wird cum Dividende/Zinsen gehandelt am 23.06.2025 und ex Dividende/Zinsen am 24.06.2025 The instrument F2P KYG4212K1040 GUSHENGTANG HLD.DL-,0001 EQUITY has its pre-dividend/interest day on 23.06.2025 and its ex-dividend/interest day on 24.06.2025...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Das sind halt die Freuden eines Preisministers, wenn ab und zu nicht alles teurer wird. - Dr. Josef Staribacher

Partner: >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram